Table 4.
Univariate analysis of overall and relapse free survival in patients with lung adenocarcinoma cancer.
| Overall survival | Relapse free survival | |||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
| Age | 0.82 | 0.55–1.22 | 0.322 | – | – | – |
| Gender | 1.05 | 0.78–1.4 | 0.760 | – | – | – |
| T classification | 1.52 | 1.26–1.82 | < 0.001 | 1.16 | 0.96–1.4 | 0.132 |
| N classification | 1.67 | 1.41–1.97 | < 0.001 | 1.15 | 0.92–1.44 | 0.228 |
| M classification | 1.4 | 1.04–1.9 | 0.029 | 0.93 | 0.68–1.28 | 0.662 |
| Radiation therapy | 1.25 | 0.89–1.75 | 0.199 | – | – | – |
| Residual tumor | 1.2 | 1.01–1.42 | 0.037 | 1.14 | 0.96–1.35 | 0.150 |
| Stage | 1.68 | 1.47–1.93 | < 0.001 | 1.51 | 1.21–1.89 | < 0.001 |
| KLRK1 | 0.69 | 0.51–0.93 | 0.016 | 0.78 | 0.57–1.07 | 0.129 |